Skip to main content

PhaseBio Pharmaceuticals Inc

PHASDelisted Dec 21, 2022
Industry
Pharmaceutical Preparations
SEC CIK
0001169245

PhaseBio Pharmaceuticals Inc was delisted on Dec 21, 2022; its insiders filed their last Form 4 on May 19, 2023; 39 institutions reported holding it in 13F filings for Q3 2022, worth $3.90M in total; no superinvestor held it.

Q2 2022 vs. Q1 2022

How the institutions holding PhaseBio Pharmaceuticals Inc changed between Q1 2022 and Q2 2022.

All holders in Q2 2022All holders in Q1 2022

13F holders of PHAS: Q1 2022 compared with Q2 2022
MeasureQ1 2022Q2 2022Change
Holders5750−7
Shares29.4M23.4M−6.00M (−20.4%)
Value$38.8M$14.1M−$24.8M (−63.8%)

New holders (6)

Institutions that held PhaseBio Pharmaceuticals Inc at the end of Q2 2022 but not at the end of Q1 2022.

Institutions new to PHAS in Q2 2022
InstitutionSharesValue% of portfolio
CHI Advisors LLC750,000$450.0K0.17%
Jane Street Group, LLC112,668$68.0K0.00%
Citadel Advisors LLC107,953$65.0K0.00%
Prudential Financial Inc44,100$26.0K0.00%
Citigroup Inc6,000$4.00K0.00%
Harbour Investments, Inc.3,600$2.00K0.00%

Sold out (13)

Institutions that held PhaseBio Pharmaceuticals Inc at the end of Q1 2022 and filed for Q2 2022 without it.